세계의 관절만곡증 시장 보고서(2025년)

Arthrogryposis Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

관절만곡증 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간의 성장은 변형성 관절증의 유병률의 상승, 이 질환의 위험을 안고 있는 인구 증가인 것으로 예측됩니다. 이 기간의 주요 동향으로는 의료 기술의 진보, 유전자 연구의 혁신, 치료법의 기술적 진보, 비외과적 치료법의 개발, 생물학적 제제나 줄기 세포 치료의 진보 등을 들 수 있습니다.

선천성 질환의 유병률 증가는 향후 수년간 관절만곡증 시장의 성장을 견인할 것으로 예측됩니다. 유병률 상승에는 출생 전 진단의 진보, 환경 노출, 유전자 변이, 라이프 스타일의 변화 등 여러 요인이 기여하고 있습니다. 예를 들어, 2023년 2월 세계보건기구(WHO)는 세계에서 매년 약 24만명의 신생아가 생후 28일 이내에 선천성 질환으로 사망하고 있다고 보고했습니다. 또한 선천성 질환은 생후 1개월부터 5세 사이에 추정 17만명의 어린이의 사망으로 이어지고 있습니다.

원격 의료 서비스의 가용성 확대는 관절만곡증 시장의 성장을 더욱 촉진할 것으로 예측됩니다. 특히 원격지나 충분한 서비스를 받지 않은 지역에서 환자의 케어에 대한 접근을 개선하면서 의료비를 삭감할 가능성에 기인하고 있습니다. 예를 들어, 2024년 5월 호주 디지털 의료 기관은 지난 2년간 95,000명 이상의 의사가 원격 의료 서비스를 활용하여 1,820만 명의 환자에게 1억 8,800만 건의 원격 의료 상담을 제공했다고 보고했습니다. 그 결과, 원격 의료 서비스 이용 증가가 관절만곡증 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 관절만곡증 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 관절만곡증 시장 : 성장률 분석
• 세계의 관절만곡증 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 관절만곡증 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 관절만곡증 전체 시장(TAM)

제6장 시장 세분화

• 세계의 관절만곡증 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 클래식 관절만곡증
• 원위 관절만곡증
• 근 감소증
• 세계의 관절만곡증 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 작업치료사
• 물리치료
• 수술
• 영상 진단
• CT 스캔
• 세계의 관절만곡증 시장 : 환자 연령별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 어린이
• 성인
• 노인
• 세계의 관절만곡증 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타 유통 채널
• 세계의 관절만곡증 시장 : 클래식 관절만곡증 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 다발성 관절 침범
• 굴곡 구축
• 심한 근력 약화
• 진행성 관절만곡증
• 지적 장애
• 세계의 관절만곡증 시장 : 원위 관절만곡증 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 고립 사지 침범
• 손과 발의 구축
• 원위 관절 구축
• 상염색체 우성 유전
• 세계의 관절만곡증 시장 : 근 감소증 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 심한 사지 구축
• 근 감소증(근 긴장 저하)
• 인지장애 없음
• 대칭적 관절 침범
• 영향을 받은 사지의 근육 발달 부족

제7장 지역별/국가별 분석

• 세계의 관절만곡증 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 관절만곡증 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 관절만곡증 시장 : 경쟁 구도
• 관절만곡증 시장 : 기업 프로파일
  • Hitachi Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
  • The Cleveland Clinic Foundation 개요, 제품 및 서비스, 전략 및 재무 분석
  • The Johns Hopkins Health System Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
  • NYU Langone Hospitals 개요, 제품 및 서비스, 전략 및 재무 분석
  • Seattle Children's Hospital 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Boston Children's Hospital
• Phoenix Children's Hospital Inc.
• Children's Healthcare of Atlanta Inc.
• The Nemours Foundation
• Shriners Hospitals for Children
• Hanger Inc.
• Texas Scottish Rite Hospital for Children
• Gillette Children's Specialty Healthcare
• Paley Orthopedic & Spine Institute LLC
• Quantum Rehab a division of Pride Mobility Products Corp.
• Obi Robot Inc.
• Gammie HomeCare LLC
• Prothotic Laboratories Inc.
• SSM Health Cardinal Glennon Children's Hospital
• Arthrogryposis Multiplex Congenita Support Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 관절만곡증 시장(2029년) : 새로운 기회를 제공하는 국가
• 관절만곡증 시장(2029년) : 새로운 기회를 제공하는 부문
• 관절만곡증 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Arthrogryposis is a group of congenital conditions marked by multiple joint contractures, leading to stiffness and restricted movement. It occurs when there is reduced fetal movement in the womb, which may be caused by neurological, muscular, or connective tissue disorders.

The main types of arthrogryposis include classic arthrogryposis, distal arthrogryposis, and amyoplasia. Classic arthrogryposis is characterized by multiple joint contractures (stiffness or fixation) present at birth, often associated with muscle weakness and limited mobility. Treatment options include occupational therapy, physical therapy, surgery, imaging diagnostics, and CT scans. The disorder can affect individuals of all ages, from children to the elderly, and treatments are available through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and other distribution methods.

The arthrogryposis market research report is one of a series of new reports from The Business Research Company that provides arthrogryposis market statistics, including the arthrogryposis industry global market size, regional shares, competitors with the arthrogryposis market share, detailed arthrogryposis market segments, market trends, and opportunities, and any further data you may need to thrive in the arthrogryposis industry. This arthrogryposis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The arthrogryposis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $0.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the rising prevalence of osteoarthritis, an increase in sports-related injuries, a growing aging population, more sedentary lifestyles, and heightened awareness of osteoarthritis therapeutics.

The arthrogryposis market size is expected to see strong growth in the next few years. It will grow to $1.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period is expected to be driven by the expanding geriatric population, a higher adoption of pain medications, an increasing number of sports injuries, the rising prevalence of osteoarthritis, and a growing population at risk for the condition. Key trends during this period include advancements in medical technology, innovations in genetic research, technological progress in treatment options, the development of non-surgical treatments, and advancements in biologics and stem cell therapies.

The increasing prevalence of congenital disorders is expected to drive the growth of the arthrogryposis market in the coming years. Congenital disorders are abnormalities that occur during fetal development, either structurally or functionally, and are present at birth. Several factors contribute to the rising prevalence of congenital disorders, including advancements in prenatal diagnostics, environmental exposures, genetic mutations, and lifestyle changes. Arthrogryposis plays a crucial role in understanding congenital disorders by emphasizing the importance of fetal movement, genetic factors, and neuromuscular development in musculoskeletal abnormalities. For example, in February 2023, the World Health Organization reported that approximately 240,000 newborns worldwide die from congenital disorders within the first 28 days of life each year. Additionally, congenital conditions lead to an estimated 170,000 child deaths between the ages of 1 month and 5 years. As a result, the increasing prevalence of congenital disorders is contributing to the growth of the arthrogryposis market.

The growing availability of telehealth services is expected to further drive the growth of the arthrogryposis market. Telehealth services use digital communication tools such as video calls, phone calls, and online messaging to provide healthcare remotely, allowing patients to receive care from home or other locations. The rise in telehealth services can be attributed to their convenience, accessibility, and potential to reduce healthcare costs while improving patient access to care, particularly in remote or underserved areas. Telehealth is beneficial for arthrogryposis patients by enabling remote consultations, early diagnosis, and ongoing management of joint contractures, improving access to specialized care for individuals with mobility challenges. For instance, in May 2024, the Australian Digital Health Agency reported that over 95,000 practitioners had utilized telehealth services, offering 118.2 million telehealth consultations to 18 million patients over the past two years. Consequently, the increasing use of telehealth services is driving the growth of the arthrogryposis market.

Companies in the arthrogryposis market are also focusing on advancing surgical techniques, such as carpal wedge osteotomy, to improve joint mobility and reduce contractures, ultimately enhancing patients' functional outcomes and quality of life. Carpal wedge osteotomy is a surgical procedure that involves removing a wedge-shaped section of bone from the wrist to correct joint deformities and improve hand function in patients with conditions such as arthrogryposis. For example, in November 2022, Akron Children's Hospital, a US-based pediatric care hospital, developed a new procedure combining carpal wedge osteotomy with flexor-pronator slide to improve joint mobility in patients with this rare condition, which is characterized by stiff or contracted joints.

Major players in the arthrogryposis market are Hitachi Ltd., The Cleveland Clinic Foundation, The Johns Hopkins Health System Corporation, NYU Langone Hospitals, Seattle Children's Hospital, Boston Children's Hospital, Phoenix Children's Hospital Inc., Children's Healthcare of Atlanta Inc., The Nemours Foundation, Shriners Hospitals for Children, Hanger Inc., Texas Scottish Rite Hospital for Children, Gillette Children's Specialty Healthcare, Paley Orthopedic & Spine Institute LLC, Quantum Rehab a division of Pride Mobility Products Corp., Obi Robot Inc., Gammie HomeCare LLC, Prothotic Laboratories Inc., SSM Health Cardinal Glennon Children's Hospital, and Arthrogryposis Multiplex Congenita Support Inc.

North America was the largest region in the arthrogryposis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arthrogryposis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the arthrogryposis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arthrogryposis market consists of revenues earned by entities by providing services such as medical diagnosis and consultation, surgical interventions, orthotic services, and pediatric care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arthrogryposis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arthrogryposis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for arthrogryposis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arthrogryposis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Classic Arthrogryposis; Distal Arthrogryposis; Amyoplasia
• 2) By Treatment Type: Occupational Therapists; Physical Therapy; Surgery; Imaging Diagnostics; CT Scan
• 3) By Patient Age: Children; Adults; Elderly
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Classic Arthrogryposis: Multiple Joint Involvement; Flexion Contractures; Severe Muscle Weakness; Progressive Arthrogryposis; Intellectual Impairment
• 2) By Distal Arthrogryposis: Isolated Limb Involvement; Contractures of Hands and Feet; Distal Joint Contractures; Autosomal Dominant Inheritance
• 3) By Amyoplasia: Severe Limb Contractures; Muscle Hypotonia (low muscle tone); No Cognitive Impairment; Symmetric Joint Involvement; Lack Of Muscle Development In Affected Limbs
• Companies Mentioned: Hitachi Ltd.; The Cleveland Clinic Foundation; The Johns Hopkins Health System Corporation; NYU Langone Hospitals; Seattle Children's Hospital
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Arthrogryposis Market Characteristics

3. Arthrogryposis Market Trends And Strategies

4. Arthrogryposis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Arthrogryposis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Arthrogryposis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Arthrogryposis Market Growth Rate Analysis
• 5.4. Global Arthrogryposis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Arthrogryposis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Arthrogryposis Total Addressable Market (TAM)

6. Arthrogryposis Market Segmentation

• 6.1. Global Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classic Arthrogryposis
• Distal Arthrogryposis
• Amyoplasia
• 6.2. Global Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Occupational Therapists
• Physical Therapy
• Surgery
• Imaging Diagnostics
• CT Scan
• 6.3. Global Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• Elderly
• 6.4. Global Arthrogryposis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Arthrogryposis Market, Sub-Segmentation Of Classic Arthrogryposis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multiple Joint Involvement
• Flexion Contractures
• Severe Muscle Weakness
• Progressive Arthrogryposis
• Intellectual Impairment
• 6.6. Global Arthrogryposis Market, Sub-Segmentation Of Distal Arthrogryposis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isolated Limb Involvement
• Contractures of Hands and Feet
• Distal Joint Contractures
• Autosomal Dominant Inheritance
• 6.7. Global Arthrogryposis Market, Sub-Segmentation Of Amyoplasia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Severe Limb Contractures
• Muscle Hypotonia (low muscle tone)
• No Cognitive Impairment
• Symmetric Joint Involvement
• Lack Of Muscle Development In Affected Limbs

7. Arthrogryposis Market Regional And Country Analysis

• 7.1. Global Arthrogryposis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Arthrogryposis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Arthrogryposis Market

• 8.1. Asia-Pacific Arthrogryposis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Arthrogryposis Market

• 9.1. China Arthrogryposis Market Overview
• 9.2. China Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Arthrogryposis Market

• 10.1. India Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Arthrogryposis Market

• 11.1. Japan Arthrogryposis Market Overview
• 11.2. Japan Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Arthrogryposis Market

• 12.1. Australia Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Arthrogryposis Market

• 13.1. Indonesia Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Arthrogryposis Market

• 14.1. South Korea Arthrogryposis Market Overview
• 14.2. South Korea Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Arthrogryposis Market

• 15.1. Western Europe Arthrogryposis Market Overview
• 15.2. Western Europe Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Arthrogryposis Market

• 16.1. UK Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Arthrogryposis Market

• 17.1. Germany Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Arthrogryposis Market

• 18.1. France Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Arthrogryposis Market

• 19.1. Italy Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Arthrogryposis Market

• 20.1. Spain Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Arthrogryposis Market

• 21.1. Eastern Europe Arthrogryposis Market Overview
• 21.2. Eastern Europe Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Arthrogryposis Market

• 22.1. Russia Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Arthrogryposis Market

• 23.1. North America Arthrogryposis Market Overview
• 23.2. North America Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Arthrogryposis Market

• 24.1. USA Arthrogryposis Market Overview
• 24.2. USA Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Arthrogryposis Market

• 25.1. Canada Arthrogryposis Market Overview
• 25.2. Canada Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Arthrogryposis Market

• 26.1. South America Arthrogryposis Market Overview
• 26.2. South America Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Arthrogryposis Market

• 27.1. Brazil Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Arthrogryposis Market

• 28.1. Middle East Arthrogryposis Market Overview
• 28.2. Middle East Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Arthrogryposis Market

• 29.1. Africa Arthrogryposis Market Overview
• 29.2. Africa Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Arthrogryposis Market Competitive Landscape And Company Profiles

• 30.1. Arthrogryposis Market Competitive Landscape
• 30.2. Arthrogryposis Market Company Profiles
  • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Cleveland Clinic Foundation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Johns Hopkins Health System Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. NYU Langone Hospitals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Seattle Children's Hospital Overview, Products and Services, Strategy and Financial Analysis

31. Arthrogryposis Market Other Major And Innovative Companies

• 31.1. Boston Children's Hospital
• 31.2. Phoenix Children's Hospital Inc.
• 31.3. Children's Healthcare of Atlanta Inc.
• 31.4. The Nemours Foundation
• 31.5. Shriners Hospitals for Children
• 31.6. Hanger Inc.
• 31.7. Texas Scottish Rite Hospital for Children
• 31.8. Gillette Children's Specialty Healthcare
• 31.9. Paley Orthopedic & Spine Institute LLC
• 31.10. Quantum Rehab a division of Pride Mobility Products Corp.
• 31.11. Obi Robot Inc.
• 31.12. Gammie HomeCare LLC
• 31.13. Prothotic Laboratories Inc.
• 31.14. SSM Health Cardinal Glennon Children's Hospital
• 31.15. Arthrogryposis Multiplex Congenita Support Inc.

32. Global Arthrogryposis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Arthrogryposis Market

34. Recent Developments In The Arthrogryposis Market

35. Arthrogryposis Market High Potential Countries, Segments and Strategies

• 35.1 Arthrogryposis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Arthrogryposis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Arthrogryposis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료